SATB2 and ovarian mucinous neoplasm: When used together, CK7 and SATB2 achieve an overall diagnostic accuracy of 95.3% in distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases, outperforming traditional panels such as CK7/CK20/CDX2 [70,71,72].